T.Sells-MarchartS.Morante-CarrielJ
Dammak, I
This study expanded far beyond just semaglutide, analyzing 39 randomized controlled trials covering all GLP-1 receptor agonists with 70,499 total participants
evidence in this specific context is limited, so consider trialling for a few weeks and stopping if there is no benefit The NHS Eatwell Guide provides a useful framework for maintaining a balanced diet when modifying food intake to manage symptoms
Sabatine MS, Leiter LA, Wiviott SD, Giugliano RP, Deedwania P, De Ferrari GM, et al
The information provided here shouldn't replace professional medical consultation, diagnosis, or treatment